Sign inJoin waitlistJoin the waitlist

SM

Steven Maron

Assistant Attending Physician · New York Presbyterian Hospital

Credentials: · · · · · · ·

History

Memorial Hospital for Cancer and allied Diseases
2019–Present

Hematology and Medical Oncology
University of Chicago Medical Center
2014–2017
Yale-New Haven Hospital
2011–2014
Sidney Kimmel Medical College at Thomas Jefferson University
2007–2011

Research

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
The Lancet Oncology · 2020 · 299 citations
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
Cancer Discovery · 2018 · Co-first of 57 authors · 257 citations
Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma
Clinical Cancer Research · 2019 · First of 14 authors · 198 citations

YJ
Yelena Janjigian
37 papers
GK
Geoffrey Ku
25 papers
LT
Laura Tang
21 papers
VS
Vivian Strong
20 papers
DI
David Ilson
19 papers
DC
Daniel Coit
17 papers
DM
Daniela Molena
16 papers
DC
Daniel Catenacci
15 papers
DJ
David Jones
14 papers
AC
Andrea Cercek
11 papers
SS
Smita Sihag
11 papers · 4 as a resident
David Solit
10 papers

Grants

Genomic Characterization and Clinical Outcomes of Cancers in WTC-Exposed Survivors & Responders
NIOSH · R21
PI · $287.2K · Sloan-Kettering Inst Can Research
2026–2028

Clinical trials

A Study of Tooth Erosion in People With Esophagogastric Cancer
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2022–2027
A Study of Amivantamab in People With Esophagogastric Cancer
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2021–2026